BioProgress completes NRobe restructuring
BioProgress are set to speed up commercialisation of NRobe, their solid oral dose system, following completion of a restructuring agreement with Magenta Oral Dose Design.
BioProgress are set to speed up commercialisation of NRobe, their solid oral dose system, following completion of a restructuring agreement with Magenta Oral Dose Design.
Cardinal Health is about to sell its drug manufacturing arm to an international private investment firm, only two months after announcing its decision to divest the segment, while its second quarter earnings doubled as a result.
Scientists hope to speed up the development of regenerative drugs for diseases such as cancer by using robotics to automate stem cell research.
Scientists have today unveiled a technique for tipping the balance in favour of antibiotics in their fight against increasingly drug-resistant 'superbugs'.
Scientists have revealed a possible reason why the Northwick Park clinical trial of a drug designed to stimulate the immune system instead led to multiple organ failure in the human volunteers.
France-based Rexam Pharma is gearing up to launch a safety add-on device that fits on to prefilled syringes to help drugmakers comply with recent legislations designed to prevent needlestick injuries.
Researchers have managed to successfully express human interferon alpha-2a in the egg whites of eggs laid by their flock of transgenic hens.
UK based researchers have added another dimension to anti-counterfeiting with an alternative Raman imaging method that is powerful enough to detect fake drugs without opening the package.